Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

被引:108
|
作者
Scalone, Luciana [1 ,2 ,3 ]
Ciampichini, Roberta [2 ]
Fagiuoli, Stefano [4 ]
Gardini, Ivan [5 ]
Fusco, Francesco [2 ]
Gaeta, Laura [4 ]
Del Prete, Anna [4 ]
Cesana, Giancarlo [1 ]
Mantovani, Lorenzo G. [2 ,6 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth, CESP, Milan, Italy
[2] CHARTA Fdn, Milan, Italy
[3] Fdn Charta, I-20122 Milan, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Patients Org EpaC ONLUS, Milan, Italy
[6] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy
关键词
Health-related quality of life (HRQoL); Chronic hepatic diseases; EQ-5D-3L; EQ-5D-5L; Psychometric performance; QUALITY-OF-LIFE; LIVER-DISEASE; SPANISH VERSION; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CANDIDATES; UTILITIES; VALIDITY;
D O I
10.1007/s11136-012-0318-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs). We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system. A total of 1,088 valid patients were recruited: 62 % male, 19-89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57-65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved. In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
引用
收藏
页码:1707 / 1716
页数:10
相关论文
共 50 条
  • [41] Evaluation of the EQ-5D-3L and 5L versions in low back pain patients
    A. M. Garratt
    H. Furunes
    C. Hellum
    T. Solberg
    J. I. Brox
    K. Storheim
    L. G. Johnsen
    Health and Quality of Life Outcomes, 19
  • [42] Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set
    Jyani, Gaurav
    Sharma, Atul
    Prinja, Shankar
    Kar, Sitanshu Sekhar
    Trivedi, Mayur
    Patro, Binod Kumar
    Goyal, Aarti
    Purba, Fredrick Dermawan
    Finch, Aureliano Paolo
    Rajsekar, Kavitha
    Raman, Swati
    Stolk, Elly
    Kaur, Manmeet
    VALUE IN HEALTH, 2022, 25 (07) : 1218 - 1226
  • [43] Evaluation of the EQ-5D-3L and 5L versions in low back pain patients
    Garratt, A. M.
    Furunes, H.
    Hellum, C.
    Solberg, T.
    Brox, J. I.
    Storheim, K.
    Johnsen, L. G.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [44] Acceptability and Validity of the EQ-5D in Patients Living With Dementia
    Michalowsky, Bernhard
    Xie, Feng
    Kohlmann, Thomas
    Graeske, Johannes
    Wuebbeler, Markus
    Thyrian, Jochen Rene
    Hoffmann, Wolfgang
    VALUE IN HEALTH, 2020, 23 (06) : 760 - 767
  • [45] The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
    Alex Bató
    Valentin Brodszky
    L. Hunor Gergely
    Krisztián Gáspár
    Norbert Wikonkál
    Ágnes Kinyó
    Ákos Szabó
    Zsuzsanna Beretzky
    Andrea Szegedi
    Éva Remenyik
    Norbert Kiss
    Miklós Sárdy
    Fanni Rencz
    Quality of Life Research, 2021, 30 : 1477 - 1490
  • [46] Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases
    Kim, MH
    Cho, YS
    Uhm, WS
    Kim, S
    Bae, SC
    QUALITY OF LIFE RESEARCH, 2005, 14 (05) : 1401 - 1406
  • [47] Validation of EQ-5D in patients with cervical cancer in Taiwan
    Hui-Chu Lang
    Linghsiang Chuang
    Shiow-Ching Shun
    Ching-Lin Hsieh
    Chung-Fu Lan
    Supportive Care in Cancer, 2010, 18 : 1279 - 1286
  • [48] Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases
    Sakthong, Phantipa
    Sonsa-ardjit, Nontapat
    Sukarnjanaset, Pattarin
    Munpan, Wipaporn
    QUALITY OF LIFE RESEARCH, 2015, 24 (12) : 3015 - 3022
  • [49] Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [50] Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups
    Ferreira, Lara N.
    Ferreira, Pedro L.
    Pereira, Luis N.
    ACTA MEDICA PORTUGUESA, 2014, 27 (02): : 236 - 245